Diabetes Management My T2D Patient was Hospitalised for HF, What is the Long-Term Effect? Presented by Prof N Tsabedze A complex HF Patient – Case StudyPresented by Prof Gardner Looking at Diabetes Through the KidneysPresented by Dr S Wadee The Place and Value of SGLT2i in the Evolving Treatment Paradigm for Type 2 Diabetes Mellitus Presented by Dr Z Stevens HEFSSA Guidelines on the horizonPresented by Prof Tsabedze Diabetes and kidney disease & EMPA-REG explained and the role of EmpagliflozinClinical Article Heart Failure in the Acute setting: the EMPULSE trial for the “win”Presented by Prof Tsabedze HeFFSA Guidelines on the horizon: Is the awesome 4 a myth or a reality in clinical practice?Presented by Prof Tsabedze SGLT2i - Practical Management Presented by Prof J Butler Moving from now to the next in heart failure treatment: Insights from EMPEROR trials. Was this a breakthrough in HFpEF Presented by Prof J Butler The danger of treatment apathyPresented by Prof Evans Contextualize high-risk vs low-risk people with type 2 diabetes Presented by Prof Evans Insulin resistance and obesity - What comes first? Presented by Prof J Dave and Dr S Ruder Combination Therapy in T2DM: A perfect pair? Presented by Dr L Lombard Has Insulin been Dethroned? Debated by Dr N Mahyoodeen and Dr A Coetzee Trial, Tried and Tested: The Empagliflozin Cardiovascular Outcomes Journey Presented by Prof Evans Diabetes, Co-morbidities and the importance of Inter-Organ Cross TalkPresented by Dr Z Bayat Slowing Down the Progression of T2D. Is It Possible and how can it be done? Presented by Prof Evans Affordability study of Empagliflozin key messages. T2 Diabetic patients at Risk for Cardiovascular and or Kidney Disease Presented by Prof Jacques R Snyman FundingPresented by Prof Jacques R Snyman It Takes Two to Tango, the Benefit of a SGLT2i CombinationPresented by Dr Gary Hudson Decisions, Decisions, Decisions in Diabetes ManagementPresented by Prof J Dave Are all SGLT2-I Created Equal? Presented by Prof Nqoba Tsabedze and Dr Jackie Goldswain Empagliflozin in HFpEF Presented by By Prof Tsabedze Moving from now to next in heart failure Presented by By Prof R Gardner Disclaimer: Any and all content of these video presentations, represents the presenters intellectual property and views and does not necessarily represent the views of CME online, Video Streaming Solutions or their suppliersn Home
